Sara Ekberg

About me
Publications
CV
Public outreach and news

About me

I am a mathematical statistician and have worked as an applied
biostatistician since 2011. Since 2016 I work in the cancer epidemiology
group [1] at the Divison of Clinical Epidemiology (Department of Medicine,
Solna). I am also registered as a PhD-student with Sandra Eloranta [2] as my
main supervisor and Karin Ekström Smedby [3] and Mats Jerkeman [4]as
co-supervisors. My research topic is studying patterns and trends in the
incidence, prevalence and survival as well as survivorship issues among
patients diagnosed with the most common non-hodgkin lymphoma subtypes in
Sweden, with a focus on Diffuse Large B-cell Lymphoma.
[1] https://ki.se/en/meds/kep-cancer-epidemiology
[2] https://ki.se/en/people/sanelo
[3] https://ki.se/en/people/kariek
[4] http://portal.research.lu.se/portal/sv/persons/mats-jerkeman(960ac58f-efc9-4246-b2b3-22c9226a529e).html

Articles

Article: HEMASPHERE. 2023;7(8):e928
Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma: The Swedish MCLcomplete Project
Jerkeman M; Ekberg S; Glimelius I; Albertsson-Lindblad A; Entrop JP; Ellin F; Sonnevi K; Lewerin C; Brandefors L; Smedby KE
Article: BLOOD ADVANCES. 2023;7(5):866-874
Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation
Ekberg S; Smedby KE; Albertsson-Lindblad A; Jerkeman M; Weibull CE; Glimelius I
Article: HEMASPHERE. 2023;7(3):e838
Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden
Weibull CE; Wasterlid T; Wahlin BE; Andersson P-O; Ekberg S; Lockmer S; Enblad G; Crowther MJ; Kimby E; Smedby KE
Article: BRITISH JOURNAL OF CANCER. 2022;127(9):1642-1649
Patient trajectories after diagnosis of diffuse large B-cell lymphoma-a multistate modelling approach to estimate the chance of lasting remission
Ekberg S; Crowther M; Harrysson S; Jerkeman M; Smedby KE; Eloranta S
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2022;198(2):267-277
Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients
Harrysson S; Eloranta S; Ekberg S; Enblad G; El-Galaly TC; Sander B; Sonnevi K; Andersson P-O; Jerkeman M; Smedby KE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;195(4):552-560
Statin use and survival in 16 098 patients with non-Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era
Branvall E; Ekberg S; Eloranta S; Wasterlid T; Birmann BM; Smedby KE
Article: JOURNAL OF INTERNAL MEDICINE. 2021;290(5):1048-1060
Myocardial infarction in diffuse large B-cell lymphoma patients - a population-based matched cohort study
Ekberg S; Harrysson S; Jernberg T; Szummer K; Andersson P-O; Jerkeman M; Smedby KE; Eloranta S
Article: BLOOD CANCER JOURNAL. 2021;11(1):9
Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
Harrysson S; Eloranta S; Ekberg S; Enblad G; Jerkeman M; Wahlin BE; Andersson P-O; Smedby KE
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2020;105(6):779-785
Concordance in survival among first-degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia
Baecklund F; Ekberg S; Rosenquist R; Askling J; Eloranta S; Smedby KE
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95(7):740-748
Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma
Wasterlid T; Harrysson S; Andersson TM-L; Ekberg S; Enblad G; Andersson P-O; Jerkeman M; Eloranta S; Smedby KE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(6):1083-1092
Trends in the prevalence, incidence and survival of non-Hodgkin lymphoma subtypes during the 21st century - a Swedish lymphoma register study
Ekberg S; Smedby K; Glimelius I; Nilsson-Ehle H; Goldkuhl C; Lewerin C; Jerkeman M; Eloranta S
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95(6):652-661
Statin use is associated with improved survival in multiple myeloma: A Swedish population-based study of 4315 patients
Branvall E; Ekberg S; Eloranta S; Wasterlid T; Birmann BM; Smedby KE
Article: FERTILITY AND STERILITY. 2020;113(3):524-532
Mortality from infancy to adolescence in singleton children conceived from assisted reproductive techniques versus naturally conceived singletons in Sweden
Rodriguez-Wallberg KA; Lundberg FE; Ekberg S; Johansson ALV; Ludvigsson JF; Almqvist C; Cnattingius S; Iliadou AN
Article: CLINICAL AND EXPERIMENTAL ALLERGY. 2020;50(2):222-230
Season of birth, childhood asthma and allergy in a nationwide cohort-Mediation through lower respiratory infections.
Almqvist C; Ekberg S; Rhedin S; Fang F; Fall T; Lundholm C
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2019;28(8):1109-1116
Sibship and dispensing patterns of asthma medication in young children-a population-based study.
Dahlén E; Ekberg S; Lundholm C; Jonsson EW; Kull I; Wettermark B; Almqvist C
Article: BREAST CANCER RESEARCH. 2018;20(1):142
No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study
Frisk G; Ekberg S; Lidbrink E; Eloranta S; Sund M; Fredriksson I; Lambe M; Smedby KE
Article: SCIENTIFIC REPORTS. 2018;8(1):16899
Dog characteristics and future risk of asthma in children growing up with dogs
Fall T; Ekberg S; Lundholm C; Fang F; Almqvist C
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2018;93(8):1020-1028
Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma
Ekberg S; Jerkeman M; Andersson P-O; Enblad G; Wahlin BE; Hasselblom S; Andersson TM; Eloranta S; Smedby KE
Article: BREAST CANCER RESEARCH AND TREATMENT. 2017;166(3):887-896
Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy
Frisk G; Tinge B; Ekberg S; Eloranta S; Backlund LM; Lidbrink E; Smedby KE
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2017;92(3):251-258
Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy
Glimelius I; Eloranta S; Ekberg S; Chang ET; Neovius M; Smedby KE
Article: JOURNAL OF CANCER SURVIVORSHIP. 2016;10(3):514-523
Lost workdays in uterine cervical cancer survivors compared to the general population: impact of treatment and relapse
Everhov AH; Ekberg S; Hirschberg AL; Bergmark K; Radestad AF; Glimelius I; Smedby KE
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2016;25(6):987-994
Work Loss Duration and Predictors Following Rectal Cancer Treatment among Patients with and without Prediagnostic Work Loss
Chen L; Glimelius I; Neovius M; Ekberg S; Martling A; Eloranta S; Smedby KE
Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(5):862-866
What is the impact of chronic systemic inflammation such as rheumatoid arthritis on mortality following cancer?
Simard JF; Ekberg S; Johansson ALV; Askling J
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2015;90(12):1128-1134
Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics
Glimelius I; Ekberg S; Jerkeman M; Chang ET; Bjorkholm M; Andersson TML; Smedby KE; Eloranta S
Article: JOURNAL OF CANCER SURVIVORSHIP. 2015;9(4):599-609
Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time-a population-based comparative study
Glimelius I; Ekberg S; Linderoth J; Jerkeman M; Chang ET; Neovius M; Smedby KE
Article: ACTA ONCOLOGICA. 2015;54(10):1770-1780
Sick leave and disability pension among Swedish testicular cancer survivors according to clinical stage and treatment
Nord C; Olofsson S-E; Glimelius I; Cedermark GC; Ekberg S; Cavallin-Stahl E; Neovius M; Jerkeman M; Smedby KE
Article: BRITISH JOURNAL OF SURGERY. 2015;102(11):1426-1432
Risk of disability pension in patients following rectal cancer treatment and surgery
Chen L; Glimelius I; Neovius M; Eloranta S; Ekberg S; Martling A; Smedby KE
Article: EUROPEAN JOURNAL OF EPIDEMIOLOGY. 2012;27(12):911-914
Familial effects on survival after myocardial infarction: a registry-based sib-pair study
Ekberg S; Ploner A; de Faire U; Pedersen NL; Bennet AM
Show more

All other publications

Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2022;196(2):437-440
Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial
Fjorden K; Ekberg S; Kuric N; Smedby KE; Lagerlof I; Larsen TS; Jorgensen JM; de Nully Brown P; Jerkeman M
Thesis / dissertation: 2020
Long-term survival and survivorship in non-Hodgkin lymphoma patients in Sweden
Ekberg, Sara
Corrigendum: JOURNAL OF CANCER SURVIVORSHIP. 2015;9(4):610-611
Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time-a population-based comparative study (vol 9, pg 599, 2015)
Glimelius I; Ekberg S; Linderoth J; Jerkeman M; Chang ET; Neovius M; Smedby KE

Employments

Statistician, Department of Medicine, Karolinska Institutet, 2016-2024

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Medicine, Solna, Karolinska Institutet, 2021

About me

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI